Radiation to the gut may boost immunotherapy for esophageal cancer
Disease control
Ongoing
This study tests whether a low dose of radiation to the small intestine, combined with immunotherapy (tislelizumab) and chemotherapy, can shrink borderline or unresectable esophageal cancer enough to allow surgery. About 43 adults with thoracic esophageal squamous cell carcinoma …
Phase: PHASE2 • Sponsor: Chuangzhen Chen • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC